Inventor · disambiguated record
Nicholas J. Boylan
Also filed as: BOYLAN NICHOLAS · BOYLAN NICHOLAS J · BOYLAN NICHOLAS JON
2 granted patents·13 pending applications·2 citations·filing 2012–2023
43Inventor score
Top patents by PatentIndex Score
15 records- 0175US10952972B2Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using samePFIZER·Filed 2018·Granted Mar 23, 2021·1 cites·10 claims
- 0262US2024197642A1Novel drug delivery composition and process for blood-brain barrier crossingCYTODIGM INC·Filed 2023·Application pending·0 cites
- 0361US10195212B2Glucocorticoid-loaded nanoparticles for prevention of corneal allograft rejection and neovascularizationUNIV JOHNS HOPKINS·Filed 2015·Granted Feb 5, 2019·1 cites·18 claims
- 0459US2021259982A1Therapeutic Nanoparticles Comprising A Therapeutic Agent And Methods of Making And Using SamePFIZER·Filed 2021·Application pending·0 cites
- 0558US2019269617A1Methods of Controlling Morphology of Polymeric NanoparticlesPFIZER·Filed 2019·Application pending·0 cites
- 0657US2021196829A1Nanoparticles with enhanced mucosal penetration or decreased inflammationUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 0753US2022175690A1Novel drug delivery composition and process for blood-brain barrier crossingPHOSPHOREX INC·Filed 2021·Application pending·0 cites
- 0847US2020037638A1FormulationsMOLECULAR INFUSIONS LLC·Filed 2019·Application pending·0 cites
- 0945US2017049709A1Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using samePFIZER·Filed 2016·Application pending·0 cites
- 1045US2022175689A1Novel drug delivery composition and process for blood-brain barrier crossingPHOSPHOREX INC·Filed 2021·Application pending·0 cites
- 1145US2017209374A1Methods of controlling the morphology of polymeric nanoparticlesPFIZER·Filed 2016·Application pending·0 cites
- 1245US2020246404A1FormulationsMOLECULAR INFUSIONS LLC·Filed 2020·Application pending·0 cites
- 1344US2014329913A1Nanoparticles with enhanced mucosal penetration or decreased inflammationUNIV JOHNS HOPKINS·Filed 2012·Application pending·0 cites
- 1444US2020253922A1Methods for non-irritating pulmonary administration of cannabinoids using soft mist inhalersMOLECULAR INFUSIONS LLC·Filed 2020·Application pending·0 cites
- 1543US2020138072A1Polymer-based oral cannabinoid and/or terpene formulationsMOLECULAR INFUSIONS LLC·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →